Abstract
Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have